CERo Therapeutics Holdings, Inc.
CERO
$0.04
$0.008.70%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.59M | 1.95M | 3.30M | 5.20M | 3.25M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.07M | 531.80K | 443.90K | 564.50K | 274.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 74.80K | 74.80K | 500.00K | -- | 187.00K |
| Total Current Assets | 2.73M | 2.55M | 4.25M | 5.77M | 3.71M |
|
|
|||||
| Total Current Assets | 2.73M | 2.55M | 4.25M | 5.77M | 3.71M |
| Net Property, Plant & Equipment | 906.90K | 1.18M | 1.46M | 1.72M | 1.99M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 174.50K | 500.00K | 500.00K | 500.00K |
| Total Assets | 3.64M | 3.91M | 6.20M | 7.99M | 6.21M |
|
|
|||||
| Total Accounts Payable | 7.58M | 7.08M | 6.21M | 6.38M | 4.51M |
| Total Accrued Expenses | 702.10K | 340.70K | 365.10K | 469.70K | 1.91M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 699.10K | 931.00K | 934.30K | 905.00K | 876.40K |
| Total Finance Division Other Current Liabilities | 105.50K | 105.50K | 105.50K | 105.50K | 105.50K |
| Total Other Current Liabilities | 105.50K | 105.50K | 105.50K | 105.50K | 105.50K |
| Total Current Liabilities | 9.09M | 8.45M | 7.62M | 7.86M | 7.40M |
|
|
|||||
| Total Current Liabilities | 9.09M | 8.45M | 7.62M | 7.86M | 7.40M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 218.30K | 461.60K | 699.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.09M | 8.45M | 7.84M | 8.32M | 8.10M |
|
|
|||||
| Common Stock & APIC | 78.13M | 73.06M | 71.31M | 73.35M | 67.14M |
| Retained Earnings | -90.84M | -86.30M | -81.44M | -76.02M | -70.92M |
| Treasury Stock & Other | -- | -- | -78.80K | -78.80K | -1.30M |
| Total Common Equity | -12.71M | -13.24M | -10.21M | -2.76M | -5.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 7.26M | 8.70M | 8.57M | 2.43M | 3.18M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 7.26M | 8.70M | 8.57M | 2.43M | 3.18M |
|
|
|||||
| Total Common Equity | -12.71M | -13.24M | -10.21M | -2.76M | -5.07M |
| Total Preferred Equity | 7.26M | 8.70M | 8.57M | 2.43M | 3.18M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.45M | -4.54M | -1.63M | -329.40K | -1.89M |
|
|
|||||